SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001654954-18-003517
Filing Date
2018-04-02
Accepted
2018-04-02 16:31:52
Documents
61
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT tenx_10k.htm 10-K 1310218
2 CONSENTS OF EXPERTS AND COUNSEL tenx_ex231.htm EX-23.1 3934
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF tenx_ex311.htm EX-31.1 13447
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE tenx_ex321.htm EX-32.1 9467
  Complete submission text file 0001654954-18-003517.txt   3983828

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tenx-20171231.xml EX-101.INS 619508
6 XBRL TAXONOMY EXTENSION SCHEMA tenx-20171231.xsd EX-101.SCH 44522
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tenx-20171231_cal.xml EX-101.CAL 37647
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tenx-20171231_def.xml EX-101.DEF 75825
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tenx-20171231_lab.xml EX-101.LAB 304066
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tenx-20171231_pre.xml EX-101.PRE 200380
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34600 | Film No.: 18729330
SIC: 8731 Services-Commercial Physical & Biological Research